Q3 22: a record-breaking year ahead

24/11/22 -"Forecasts for a record year were not dented in Q3 22. AvH now boasts a strengthened liquidity position of €512m (vs. €213m in H1) driven by the Anima divestment. With a record order book for its ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

24/11/22

Download

You may also be interested by these reports :

19/02/26

Euronext NV

Euronext’s Q4 results delivered a solid 10% revenue growth, fuelled by Capital Markets and the ATHEX consolidation. However, an opex miss (+14% yoy), ...

13/02/26

ADYEN

Entry point or shift in paradigm ?

13/02/26

Exor

We have updated our estimates following the recent preliminary results announced by Stellantis. As a reminder, since Exor’s reclassification as an ...

13/02/26

Deutsche Boerse

Deutsche Boerse delivered solid Q4 results, with 7% growth in net revenue (ex-treasury) driven by Software and Securities Services. Key highlights ...

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue

Ackermans & van Haaren